Abstract
The polymerase chain reaction and direct sequencing were used to determine the nature of the mutations in the antithrombin III (AT3) gene in seven unrelated patients with familial antithrombin III (ATIII) deficiency and recurrent venous thrombosis. Three novel mutations were found, two associated with a type I deficiency state (Pro80-->Thr and His120-->Tyr) manifesting reduced synthesis of ATIII. The other novel lesion (Met251-->Ile) was associated with a dysfunctional ATIII protein (type II ATIII deficiency) and is predicted to interfere either with a heparin-induced conformational change in the ATIII molecule or with docking to thrombin. A novel polymorphism (Tyr158-->Cys) was also found to occur in several individuals of Scandinavian origin.
MeSH Terms
Amino Acid Sequence
Antithrombin III/chemistry,genetics
Antithrombin III Deficiency
Base Sequence
DNA Mutational Analysis
Exons/genetics
Female
Humans
Male
Models, Molecular
Molecular Sequence Data
Point Mutation/genetics
Polymorphism, Restriction Fragment Length
Protein Structure, Secondary
Recurrence
Scandinavian and Nordic Countries
Thrombin/chemistry
Thrombophlebitis/ethnology,genetics
Whites
Chemicals
Antithrombin III
Thrombin
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Millar D S
Charter Molecular Genetics Laboratory, Thrombosis Resarch Institute, London, UK.
Wacey A I
Ribando J
Melissari E
Laursen B
Woods P
Kakkar V V
Cooper D N
References (17)
17 references, click to expand
-
Antithrombin III mutation database: first update. For the Thrombin and its Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
Thromb Haemost. 1993 Aug 2;70(2):361-9
PMID: 8236149
-
DdeI polymorphism in intron 5 of the ATIII gene.
Nucleic Acids Res. 1990 Sep 25;18(18):5583
PMID: 1977130
-
Binding of heparin to human antithrombin III activates selective chemical modification at lysine 236. Lys-107, Lys-125, and Lys-136 are situated within the heparin-binding site of antithrombin III.
J Biol Chem. 1989 Feb 25;264(6):3111-5
PMID: 2492530
-
A player of many parts: the spotlight falls on thrombin's structure.
Thromb Res. 1993 Jan 1;69(1):1-58
PMID: 8465268
-
Recurrent deletion in the human antithrombin III gene.
Blood. 1991 Aug 15;78(4):1027-32
PMID: 1868237
-
Molecular basis of inherited human antithrombin deficiency.
Blood. 1992 Nov 1;80(9):2159-71
PMID: 1421387
-
Complete nucleotide sequence of the antithrombin gene: evidence for homologous recombination causing thrombophilia.
Biochemistry. 1993 Apr 27;32(16):4216-24
PMID: 8476848
-
Antithrombin III Milano 2: a single base substitution in the thrombin binding domain detected with PCR and direct genomic sequencing.
Nucleic Acids Res. 1989 Dec 25;17(24):10511
PMID: 2602168
-
(ATT) trinucleotide repeats in the antithrombin gene and their use in determining the origin of repeated mutations.
Hum Mutat. 1994;4(1):31-41
PMID: 7951256
-
Antithrombin Dublin (-3 Val----Glu): an N-terminal variant which has an aberrant signal peptidase cleavage site.
FEBS Lett. 1990 Oct 29;273(1-2):87-90
PMID: 1977621
-
Antithrombin-III Denver, a reactive site variant.
J Biol Chem. 1987 Jan 25;262(3):1044-8
PMID: 3805013
-
Isolation of a cDNA clone for human antithrombin III.
J Biol Chem. 1983 Jul 10;258(13):8389-94
PMID: 6305982
-
Heparin binding site, conformational change, and activation of antithrombin.
Biochemistry. 1992 Dec 22;31(50):12629-42
PMID: 1366018
-
cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placenta.
J Biol Chem. 1987 Mar 15;262(8):3718-25
PMID: 3029122
-
Antithrombin and its deficiency states.
Blood Coagul Fibrinolysis. 1992 Jun;3(3):315-41
PMID: 1643210
-
Crystal structure of cleaved bovine antithrombin III at 3.2 A resolution.
J Mol Biol. 1993 Jul 5;232(1):223-41
PMID: 8331659
-
Human antithrombin II (AT3) gene length polymorphism revealed by the polymerase chain reaction.
Nucleic Acids Res. 1989 Aug 11;17(15):6433
PMID: 2771663